Keyphrases
Insulin Resistance
100%
Insulin Sensitivity
100%
Type 2 Diabetes Mellitus (T2DM)
100%
Palmitate
100%
HepG2 Cells
100%
Odd-chain Fatty Acids
100%
Hepatocytes
71%
Steatohepatitis
42%
Monounsaturated Fatty Acids
42%
Fatty Acids
28%
Control Subjects
14%
Liver
14%
Healthy Controls
14%
In Vitro Model
14%
Plasma Parameters
14%
Lipids
14%
Obesity
14%
Acid Activation
14%
Protective Effect
14%
T2DM Patients
14%
Fatty Acid Composition
14%
Fatty Acid Synthase
14%
Multiple Regression Model
14%
Fasting Plasma Glucose
14%
Gas Chromatography
14%
Desaturase
14%
Stearoyl
14%
Saturated Fatty Acids
14%
Cellular Dysfunction
14%
Plasma Free Fatty Acids
14%
Fenofibrate
14%
Glycogen Content
14%
Effect Mechanism
14%
Fatty Acid Metabolism
14%
Hepatic Lipid Accumulation
14%
GW6471
14%
PPAR Antagonist
14%
Plasma Fatty Acid Profile
14%
Fatty Acid Accumulation
14%
PPAR Agonists
14%
Fatty Acid Transport
14%
Biochemistry, Genetics and Molecular Biology
Insulin Resistance
100%
Insulin Sensitivity
100%
Peroxisome Proliferator-Activated Receptor
100%
Saturated Fatty Acid
100%
Odd-Chain Fatty Acid
100%
Hepatocyte
71%
Monounsaturated Fat
42%
Fatty Acid Blood Level
28%
Metabolic Pathway
14%
Lipid
14%
Upregulation
14%
Lipid Storage
14%
Glucose Blood Level
14%
Blood Level
14%
Tumor Necrosis Factor
14%
PPAR Agonist
14%
Gas Chromatography
14%
Fatty Acid Synthase
14%
Lipid Liver Level
14%
Fatty Acid Transport
14%
Fenofibrate
14%
Pharmacology, Toxicology and Pharmaceutical Science
Insulin Resistance
100%
Palmitic Acid
100%
Fatty Acid
100%
Peroxisome Proliferator Activated Receptor
100%
Saturated Fatty Acid
100%
Monounsaturated Fatty Acid
42%
Tumor Necrosis Factor
14%
Non Insulin Dependent Diabetes Mellitus
14%
Fatty Acid Synthase
14%
PPAR Agonist
14%
Fenofibrate
14%
Peroxisome Proliferator Activated Receptor Antagonist
14%